Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
0.8000
+0.0188 (2.41%)
At close: Jul 2, 2025, 4:00 PM
0.8100
+0.0100 (1.25%)
Pre-market: Jul 3, 2025, 8:15 AM EDT
Imunon Market Cap
Imunon has a market cap or net worth of $17.04 million as of July 3, 2025. Its market cap has increased by 62.31% in one year.
Market Cap
17.04M
Enterprise Value
15.18M
1-Year Change
62.31%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since March 1, 1999, Imunon's market cap has decreased from $37.80M to $17.04M, a decrease of -54.91%. That is a compound annual growth rate of -2.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 11.70M | -15.22% |
| Dec 31, 2024 | 13.80M | 115.63% |
| Dec 29, 2023 | 6.40M | -36.00% |
| Dec 30, 2022 | 10.00M | -78.59% |
| Dec 31, 2021 | 46.70M | 75.56% |
| Dec 31, 2020 | 26.60M | -31.62% |
| Dec 31, 2019 | 38.90M | 47.35% |
| Dec 31, 2018 | 26.40M | -38.60% |
| Dec 29, 2017 | 43.00M | 444.30% |
| Dec 30, 2016 | 7.90M | -82.29% |
| Dec 31, 2015 | 44.60M | -4.09% |
| Dec 31, 2014 | 46.50M | -12.10% |
| Dec 31, 2013 | 52.90M | -81.56% |
| Dec 31, 2012 | 286.80M | 531.72% |
| Dec 30, 2011 | 45.40M | 73.95% |
| Dec 31, 2010 | 26.10M | -34.09% |
| Dec 31, 2009 | 39.60M | 77.58% |
| Dec 31, 2008 | 22.30M | -30.75% |
| Dec 31, 2007 | 32.20M | 57.07% |
| Dec 29, 2006 | 20.50M | -52.76% |
| Dec 30, 2005 | 43.40M | -52.62% |
| Dec 31, 2004 | 91.60M | -52.73% |
| Dec 31, 2003 | 193.80M | 366.99% |
| Dec 31, 2002 | 41.50M | -26.29% |
| Dec 31, 2001 | 56.30M | -12.71% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.81B |
| Johnson & Johnson | 367.53B |
| AbbVie | 327.88B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 283.00B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.64B |
| AstraZeneca | 215.00B |